• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多动脉期 MRI 描绘了肝癌高危患者肝脏观察中动脉期强化(APHE)亚型的不一致性。

Multi-arterial phase MRI depicts inconsistent arterial phase hyperenhancement (APHE) subtypes in liver observations of patients at risk for hepatocellular carcinoma.

机构信息

Liver Imaging Group, Department of Radiology, University of California San Diego, La Jolla, CA, 92093, USA.

Department of Mathematics and Statistics, San Diego State University, San Diego, CA, 92182, USA.

出版信息

Eur Radiol. 2021 Oct;31(10):7594-7604. doi: 10.1007/s00330-021-07924-8. Epub 2021 Apr 19.

DOI:10.1007/s00330-021-07924-8
PMID:33876298
Abstract

OBJECTIVES

According to LI-RADS, a major discriminating feature between hepatocellular carcinoma (HCC) and non-HCC malignancies is the subtype of arterial phase hyperenhancement (APHE). The aim of this study was to investigate whether APHE subtypes are consistent across multi-arterial phase (mHAP) MRI acquisitions while evaluating reader agreement. Secondarily, we investigated factors that may affect reader agreement for APHE subtype.

METHODS

In this retrospective study, consecutive patients with liver cirrhosis and focal observations who underwent mHAP were included. Five radiologists reviewed MR images in 2 reading sessions. In reading session 1, individual AP series were reviewed and scored for presence of APHE and subtype. In reading session 2, readers scored observations' major and ancillary features and LI-RADS category in the complete MRI examination. Reader agreement was calculated using Fleiss' kappa for binary outcomes and Kendall's coefficient of concordance for LI-RADS categories. Univariate mixed effects logistic regressions were performed to investigate factors affecting agreement.

RESULTS

In total, 61 patients with 77 focal observations were analyzed. Of observations unanimously scored as having APHE, 27.7% showed both rim and nonrim subtypes on mHAP. Inter-reader agreement for APHE subtype ranged from 0.49 (95% CI: 0.33, 0.64) to 0.57 (95% CI: 0.40, 0.74) between reading sessions. Observation size had a trend level effect on rim APHE agreement (p = 0.052).

CONCLUSION

Approximately 1/3 of observations demonstrated inconsistent APHE subtype during mHAP acquisition. Small lesions were particularly challenging. Further guidance on APHE subtype classification, especially when applied to mHAP, could be a focus of LI-RADS refinement.

KEY POINTS

• In a cohort of patients at risk for HCC, 28% of the observations showed inconsistent arterial phase hyperenhancement (APHE) subtypes (rim and nonrim) on multi-arterial phase imaging according to the majority score of 5 independent readers. • Inconsistent APHE subtypes may challenge reliable imaging diagnosis, i.e., LI-RADS categorization, of focal liver observations in patients at risk for HCC.

摘要

目的

根据 LI-RADS,肝细胞癌(HCC)与非 HCC 恶性肿瘤的主要鉴别特征是动脉期强化(APHE)亚型。本研究旨在探讨在评估读者间一致性的同时,多动脉期(mHAP)MRI 采集时 APHE 亚型是否一致。其次,我们探讨了可能影响 APHE 亚型读者间一致性的因素。

方法

本回顾性研究纳入了连续接受 mHAP 检查且有局灶性表现的肝硬化患者。5 名放射科医生在 2 次阅读会议中分别对 MRI 图像进行了回顾和评分。在第 1 次阅读会议中,对各动脉期序列进行评分,以确定是否存在 APHE 及其亚型。在第 2 次阅读会议中,读者对完整 MRI 检查中的主要和辅助特征及 LI-RADS 分类进行评分。采用 Fleiss'kappa 评估二分类资料的读者间一致性,采用 Kendall 系数评估 LI-RADS 分类的读者间一致性。采用单因素混合效应逻辑回归分析影响一致性的因素。

结果

共分析了 61 例患者的 77 个局灶性观察结果。在所有一致被评为存在 APHE 的观察中,27.7%在 mHAP 上显示出边缘和非边缘亚型。在阅读会议之间,APHE 亚型的读者间一致性范围为 0.49(95%CI:0.33,0.64)至 0.57(95%CI:0.40,0.74)。观察大小对边缘型 APHE 一致性有趋势影响(p=0.052)。

结论

在 mHAP 采集过程中,约有 1/3的观察结果显示出动脉期强化亚型不一致(边缘和非边缘)。小病变尤其具有挑战性。对动脉期强化亚型分类的进一步指导,特别是在应用于 mHAP 时,可能是 LI-RADS 细化的重点。

关键点

  1. 在 HCC 高危患者队列中,根据 5 名独立读者的多数评分,28%的观察结果在多动脉期成像上显示出不一致的动脉期强化(APHE)亚型(边缘型和非边缘型)。

  2. 不一致的 APHE 亚型可能会对 HCC 高危患者的局灶性肝脏观察结果的可靠影像学诊断(即 LI-RADS 分类)构成挑战。

相似文献

1
Multi-arterial phase MRI depicts inconsistent arterial phase hyperenhancement (APHE) subtypes in liver observations of patients at risk for hepatocellular carcinoma.多动脉期 MRI 描绘了肝癌高危患者肝脏观察中动脉期强化(APHE)亚型的不一致性。
Eur Radiol. 2021 Oct;31(10):7594-7604. doi: 10.1007/s00330-021-07924-8. Epub 2021 Apr 19.
2
The timing phase affected the inconsistency of APHE subtypes of liver observations in patients at risk for HCC on the multi-hepatic arterial phase imaging.时间分期影响了多肝动脉期成像中 HCC 高危患者的 APHE 亚型肝观察的不一致性。
Abdom Radiol (NY). 2024 Apr;49(4):1092-1102. doi: 10.1007/s00261-023-04096-5. Epub 2024 Jan 10.
3
Extended application of subtraction arterial phase imaging in LI-RADS version 2018: a strategy to improve the diagnostic performance for hepatocellular carcinoma on gadoxetate disodium-enhanced MRI.在 LI-RADS 版本 2018 中扩展减法动脉期成像的应用:一种提高钆塞酸二钠增强 MRI 诊断肝细胞癌的策略。
Eur Radiol. 2021 Mar;31(3):1620-1629. doi: 10.1007/s00330-020-07229-2. Epub 2020 Sep 4.
4
Does quantitative assessment of arterial phase hyperenhancement and washout improve LI-RADS v2018-based classification of liver lesions?动脉期增强程度和廓清率的定量评估是否能提高基于 LI-RADS v2018 的肝脏病变分类?
Eur Radiol. 2020 May;30(5):2922-2933. doi: 10.1007/s00330-019-06596-9. Epub 2020 Feb 4.
5
Liver Imaging Reporting and Data System: Discordance Between Computed Tomography and Gadoxetate-Enhanced Magnetic Resonance Imaging for Detection of Hepatocellular Carcinoma Major Features.肝脏影像报告和数据系统:计算机断层扫描与钆塞酸二钠增强磁共振成像在检测肝细胞癌主要特征方面的不一致性
J Comput Assist Tomogr. 2018 Jan/Feb;42(1):155-161. doi: 10.1097/RCT.0000000000000642.
6
Increasing the sensitivity of LI-RADS v2018 for diagnosis of small (10-19 mm) HCC on extracellular contrast-enhanced MRI.提高 LI-RADS v2018 对细胞外对比增强 MRI 中小肝癌(10-19mm)诊断的灵敏度。
Abdom Radiol (NY). 2021 Apr;46(4):1530-1542. doi: 10.1007/s00261-020-02790-2. Epub 2020 Oct 11.
7
Inter-reader reliability of contrast-enhanced ultrasound Liver Imaging Reporting and Data System: a meta-analysis.对比增强超声肝脏成像报告和数据系统的读者间可靠性:一项荟萃分析。
Abdom Radiol (NY). 2021 Oct;46(10):4671-4681. doi: 10.1007/s00261-021-03169-7. Epub 2021 Jun 22.
8
Can absolute arterial phase hyperenhancement improve sensitivity of detection of hepatocellular carcinoma in indeterminate nodules on CT?绝对动脉期强化能否提高 CT 平扫不确定结节中肝细胞癌的检出率?
Eur Radiol. 2024 Apr;34(4):2256-2268. doi: 10.1007/s00330-023-10237-7. Epub 2023 Sep 30.
9
An improved diagnostic algorithm for subcentimeter hepatocellular carcinoma on gadoxetic acid-enhanced MRI.基于钆塞酸增强 MRI 的亚厘米肝癌改良诊断算法。
Eur Radiol. 2023 Apr;33(4):2735-2745. doi: 10.1007/s00330-022-09282-5. Epub 2022 Dec 6.
10
Fat-containing hepatocellular carcinoma in patients with cirrhosis: proposal of a diagnostic modification regarding enhancement characteristics.肝硬化患者含脂肝细胞癌:关于增强特征的诊断修改建议。
Eur Radiol. 2024 Apr;34(4):2283-2293. doi: 10.1007/s00330-023-10236-8. Epub 2023 Oct 11.

引用本文的文献

1
The timing phase affected the inconsistency of APHE subtypes of liver observations in patients at risk for HCC on the multi-hepatic arterial phase imaging.时间分期影响了多肝动脉期成像中 HCC 高危患者的 APHE 亚型肝观察的不一致性。
Abdom Radiol (NY). 2024 Apr;49(4):1092-1102. doi: 10.1007/s00261-023-04096-5. Epub 2024 Jan 10.
2
Nomogram development and validation to predict Ki-67 expression of hepatocellular carcinoma derived from Gd-EOB-DTPA-enhanced MRI combined with T1 mapping.基于Gd-EOB-DTPA增强MRI联合T1映射预测肝细胞癌Ki-67表达的列线图构建与验证
Front Oncol. 2022 Oct 14;12:954445. doi: 10.3389/fonc.2022.954445. eCollection 2022.